Burosumab
Generic name: Burosumab
Brand names: Crysvita
Dosage form: subcutaneous solution (twza 10 mg/mL; twza 20 mg/mL; twza 30 mg/mL)
Drug class:
Miscellaneous metabolic agents
Usage of Burosumab
Burosumab is a monoclonal antibody that targets and blocks the activity of a blood protein called FGF23. In a genetic condition called X-linked hypophosphatemia (HYE-poe-fos-fa-TEEM-ee-a), low phosphate levels in blood are caused by abnormally high levels of FGF23 protein, which causes the kidneys to stop reabsorbing phosphate into the bloodstream.
Blocking the FGF23 protein allows the kidneys to restore and maintain normal phosphate levels. Phosphate is important for the strength of your bones and teeth. Low phosphate levels can lead to bone deformities and growth problems.
Burosumab is used to normalize phosphate levels in adults and children who are at least 1 year old and have X-linked hypophosphatemia.
Burosumab may also be used for purposes not listed in this medication guide.
Burosumab side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Common side effects of burosumab may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Burosumab
You should not use burosumab if you are allergic to it, or if you have:
Tell your doctor if you have ever had:
It is not known whether burosumab will harm an unborn baby. Tell your doctor if you are pregnant or if you become pregnant while using burosumab.
It may not be safe to breast-feed while using this medicine. Ask your doctor about any risk.
Burosumab is not approved for use by anyone younger than 1 year old.
Relate drugs
- Amvuttra
- Asfotase alfa
- Crysvita
- Myalept
- Burosumab
- Burosumab-twza
- Cerdelga
- Eliglustat
- Fosdenopterin
- Galafold
- Givlaari
- Givosiran
- Inotersen
- Kuvan
- Lonafarnib
- Lumasiran
- Metreleptin
- Migalastat
- Miglustat
- Mitapivat
- Nitisinone
- Nityr
- Nulibry
- Onpattro
- Opfolda
- Orfadin
- Oxlumo
- Palynziq
- Patisiran
- Pegvaliase
- Pegvaliase-pqpz
- Pyrukynd
- Pyrukynd Taper Pack
- Rivfloza
- Sapropterin
- Strensiq
- Tegsedi
- Vutrisiran
- Zavesca
- Zokinvy
How to use Burosumab
Your doctor will perform blood tests to make sure you do not have conditions that would prevent you from safely using burosumab.
At least 1 week before your first injection, stop using oral phosphate and vitamin D medications.
Burosumab is injected under the skin, once every 2 weeks in children and once every 4 weeks in adults.
A healthcare provider will give you this injection.
Burosumab doses are based on weight in children. Your child's dose needs may change if the child gains or loses weight.
You may need frequent medical tests. Even if you have no symptoms, tests can help your doctor determine if this medicine is effective.
Warnings
You should not use burosumab if you have severe kidney disease, or if you currently take phosphate or vitamin D by mouth.
What other drugs will affect Burosumab
Other drugs may affect burosumab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions